6 August 2020 - Deborah Wilkes
Thornton & Ross has appointed Mick Cox as vice-president for consumer healthcare in the UK and Craig Fletcher as regional supply chain director UK.
Cox joins the Stada subsidiary from GlaxoSmithKline (GSK) Consumer Healthcare where he spent 13 years, most recently as vice-president for business integration.
His remit at Thornton & Ross is to drive sales growth of the company’s product portfolio which includes the Cetraben, Covonia, Hedrin, Natures Aid, Nizoral, Oilatum, Savlon, Setlers, and Zoflora brands.
Thornton & Ross said Cox had a “wealth of experience in building high-profile, global brands”.
During his time at GSK, Cox was vice-president and global business leader for the oral health brand Sensodyne which has seen rapid sales growth in recent years and has annual sales in excess of GBP1 billion (USD1.3 billion).
Prior to joining GSK, Cox worked for Kimberly-Clark and Pfizer’s consumer healthcare business.
Craig Fletcher’s remit
Meanwhile, Fletcher’s remit includes bringing Thornton & Ross’ existing supply chain teams together as one team. His previous positions include supply chain director at sports-nutrition company Science in Sport, global planning manager at healthcare company Scapa Group, and UK supply chain director at consumer healthcare company SSL International.
Recent appointment of Stephen Makin
The two appointments come soon after Thornton & Ross appointed Stephen Makin as vice president OTC research and development. Makin spent 17 years with GSK where his roles included vice-president Sensodyne R&D, vice-president skin health R&D and vice-president pain relief R&D.